Reports for TEVA-PROCTOSONE
Brand name TEVA-PROCTOSONE |
|---|
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02226383 |
Ingredients
HYDROCORTISONE ESCULIN DIBUCAINE HYDROCHLORIDE FRAMYCETIN SULFATE |
Ingredient Strength
0.5 % 1 % 0.5 % 1 % |
ATC Code
C05AA |
ATC Descriptor
AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-PROCTOSONE | 15G | Resolved | 2019-07-02 | 2025-04-25 | 88222 |
| TEVA-PROCTOSONE | 30G | Resolved | 2019-07-02 | 2025-04-25 | 88225 |
Showing 1 to 2 of 2
Discontinuation reports
| Brand name | Packaging size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-PROCTOSONE | 15 & 30g | Discontinued | 2025-04-25 | 2025-04-25 | 255840 |
Showing 1 to 1 of 1